DFX Intelligence

Data Factory

VentureFirmpe with venture activity · probableregistered_investment_adviser

Petrichor Healthcare Capital Management LP

Venture Capital

New York, NY

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:b3985662-0310-4972-bfab-d2421adc8bb2

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 4:23 AM UTC and rebuilt at most every 15 minutes.

Relationships: 42
Dated events: 4
On other graphs: 3
Observed: Sep 12, 2026 to Sep 17, 2026
54 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Independent Sponsorsidentity

Petrichor Healthcare Capital Management LP

Capital provider to sponsors · shared crd

Private Equityidentity

Petrichor Healthcare Capital Management LP

Private equity manager · shared crd

RIA / Wealth Managementidentity

PETRICHOR HEALTHCARE CAPITAL MANAGEMENT LP

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 1
Vintages: 2022 to 2022
Reported GAV: $281Mgross asset value on Form ADV; never dry powder
Regulatory AUM: $966M
Funds with fundraising evidence: 0derived
Investments: 18
Portfolio companies: 18
Investments, 12m: 18
Partner-attributed: 0
People: 21
Investment professionals: 14derived
Co-investors: 0derived
LP relationships: 0
Stated sectors: healthcare,biotech,medtechas stated by the firm
Stated stages: growth
Latest Form D: Mar 15, 2023
Latest ADV filing: Mar 31, 2026
Website: petrichorcap.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV	LPs
Petrichor Scion Therapeutics LLC	2022	Active deployment	$172M	$281M	0

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
Fennec	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Geneoscopy, Inc	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Group	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Itm	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Lumiradx	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Palvella	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Persivia	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Tourmaline Text	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Vero Vector	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Scion Life Sciences	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Ascend Gene Cell Therapies	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Aurion	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Avalo	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Clearpoint neuro	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Cornea Gen	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Cryoport systems	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Egetis logotype	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Evergreen Theragnostics Logos 01	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
HLM Management Co., LLC	Petrichor Healthcare Capital Management LP	1	1	Sep 16, 2026	One time
Iselect Fund Management, LLC	Petrichor Healthcare Capital Management LP	1	1	Sep 16, 2026	One time
Petrichor Healthcare Capital Management LP	Atropos Capital Management, LLC	1	1	Sep 16, 2026	One time

Relationships

Invested in (18)

→ Tourmaline TextCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Vero VectorCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Scion Life SciencesCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Ascend Gene Cell TherapiesCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ AurionCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ AvaloCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Clearpoint neuroCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Cornea GenCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Cryoport systemsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Egetis logotypeCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Evergreen Theragnostics Logos 01CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ FennecCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Geneoscopy, IncCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ GroupCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ItmCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ LumiradxCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ PalvellaCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ PersiviaCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Employs (22)

→ Eidul HosseinPersonDirector of Finance
factThe subject's own site
→ Peter S. GreenleafPersonAdvisor
factThe subject's own site
→ Jeffrey EdelmanPersonChief Compliance Officer
factThe subject's own site
→ Scion Life SciencesPersonTeam Portfolio News Scion Life Sciences Contact Investors
factThe subject's own site
→ Tadd WesselPersonFounder and Managing Partner
factThe subject's own site
→ Patrick LallyPersonPartner
factThe subject's own site
→ Michael BeechamPersonPartner
factThe subject's own site
→ Lucy BurkePersonSenior Associate
factThe subject's own site
→ Thomas LeichnerPersonAssociate
factThe subject's own site
→ Andrew DavisPersonAssociate
factThe subject's own site
→ Paul SekhriPersonPetrichor Operating Partner
factThe subject's own site
→ Don HardisonPersonPetrichor Operating Partner
factThe subject's own site
→ Samuel HallPersonFounder, Managing Partner Scion
factThe subject's own site
→ Aaron KantoffPersonFounder, Managing Partner Scion
factThe subject's own site
→ Andreas LoewPersonPartner
factThe subject's own site
→ Megan BlewettPersonPrincipal
factThe subject's own site
→ Wiliam ChourPersonAssociate
factThe subject's own site
→ Samuel HendelPersonAssociate
factThe subject's own site
→ Elliot WarnerPersonAssociate
factThe subject's own site
→ David KatonaPersonHead of Business Development & Investor Relations
factThe subject's own site
→ Tadd Seaton WesselPersonManaging Member
Nov 1, 2016 to presentfactForm ADV
→ Baabur KhondkerPersonChief Financial Officer And Chief Compliance Officer
Mar 1, 2020 to Sep 30, 2024inferenceForm ADV

Manages (1)

→ Petrichor Scion Therapeutics LLCFundVenture Capital Fund
Mar 31, 2022 to presentfactForm ADV

Owns (1)

← Phcm GP LLCFirmGeneral Partner
Nov 1, 2016 to presentfactForm ADV

Dated events

1 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Sep 30, 2024
Person left
Baabur Mohammad Sattar Khondker (Chief Financial Officer And Chief Compliance Officer) no longer on Schedule A of Petrichor Healthcare Capital Management LP
Form ADVobserved 6 days ago
Occurred
Mar 1, 2020
Person joined
Baabur Khondker joined Schedule A of Petrichor Healthcare Capital Management LP as Chief Financial Officer And Chief Compliance Officer
Form ADVobserved 6 days ago
Occurred
Jul 14, 2017
Adviser's first ADV filing
Petrichor Healthcare Capital Management LP first filed Form ADV (ERA)
Form ADVobserved 6 days ago

Show 1 bookkeeping events

Occurred
Mar 31, 2022
Petrichor Scion Therapeutics LLC first reported on Form ADV by Petrichor Healthcare Capital Management LP (Venture Capital Fund), GAV $106,950,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV), 1 work email (firm website) · as of 2026-09-17

Also named here, with no published line of their own (reach them through the firm): Eidul Hossein (Director of Finance), Peter S. Greenleaf (Advisor), Jeffrey Edelman (Chief Compliance Officer), Scion Life Sciences (Team Portfolio News Scion Life Sciences Contact Investors), Tadd Wessel (Founder and Managing Partner), Patrick Lally (Partner), Michael Beecham (Partner), Lucy Burke (Senior Associate), Thomas Leichner (Associate), Andrew Davis (Associate), Paul Sekhri (Petrichor Operating Partner), Don Hardison (Petrichor Operating Partner).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:b3985662-0310-4972-bfab-d2421adc8bb2
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 44 h ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Petrichor Healthcare Capital Management LP

Venture Capital

New York, NY

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:b3985662-0310-4972-bfab-d2421adc8bb2

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 4:23 AM UTC and rebuilt at most every 15 minutes.